International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal.

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-16-02-2020-259
Total View : 129

Abstract : Diabetic kidney disease (DKD) is the most prevalent cause of chronic kidney disease, Due to decreased sensitivity of microalbuminuria for early detection of DKD, there is new shift to other markers for early detection and prediction of DKD and to delay or prevent the development of end stage renal disease. To evaluate fibroblast growth factor 21(FGF21) as an early marker of diabetic kidney disease. 176 participants were involved and divided into 4 groups; group I comprised 44 healthy volunteers, group II comprised 44 patients with type 2 diabetes with normoalbumiuruia, group III comprised 44 patients with type 2 diabetes with microalbuminuria and group IV comprised 44 patients with type 2 diabetes with macroalbuminuria. All participants were submitted to detail clinical examination, laboratory investigations, complete blood count, urine analysis, fasting blood glucose (FBG), random blood glucose (RBG), glycated haemoglobin (HbA1c), serum creatinine, eGFR, albumin creatinine ratio (ACR), lipid profile and serum FGF21 levels assays. FGF21 levels were significantly higher in albuminuria groups than diabetic with normoalbuminuria and control groups. FGF21 was positively correlated with duration of diabetes, FBG, RBG, HbA1C, s.creatinine, ACR, total cholesterol (TC) and triglycerides (TG). At cutoff value more than 492pg/ml, FGF-21 yielded 82.2% sensitivity and 89.1% specificity for the differentiation of microalbuminuria. Serum FGF21 could be used as an early marker for diagnosis and identifying DKD.
Full article
International Medical Journal
Journal ID : IMJ-16-02-2020-257
Total View : 122

Abstract : Irisin was found in cerebrospinal fluid and the paraventricular nucleus in humans suggesting that it has central as well as peripheral metabolic functions. No data available demonstrating the effect of upper or lower motor neuron lesion on irisin levels. We hypothesized that irisin levels are changed after motor neuron lesion and these changes are correlated with body weight changes observed after UMNL or LMNL. 40 male rats were divided into 4 groups; control for UMNL, UMNL group, control for LMNL and LMNL group. Body Weight (BW), Body mass index (BMI), plasma and muscle tissue irisin levels were measured. Highly significant increases in plasma and muscle tissue irisin levels were found in UMNL and LMNL groups compared with control groups (p≤0.001 and p≤0.05). Significant reductions in BW and BMI were found in UMNL and LMNL groups compared with their control groups (p≤0.05). Also, a significant negative correlation was found between irisin and body weight (r*=- 0.7975, p≤0.05) and body mass index (r*= - 0.9792, p≤0.05) in all groups. We suggested that irisin might have an important role in weight reduction observed UMNL and LMNL.
Full article
International Medical Journal
Journal ID : IMJ-16-02-2020-256
Total View : 129

Abstract : The increase in caesarean section rates seems uncontrollable, with no signs that it is slowing down. This descriptive cross-sectional study was conducted during the period from the 1st of January through June 2019 in four major teaching hospitals in Baghdad. The study was designed to be of two parts; the first targeted women to search for reasons behind choosing caesarean section as a mode of delivery, the second part included 30 obstetricians to dig for their opinion about that. The major medical reason was Cephalo-pelvic disproportion (27.8%), 87% of the women reported fear from normal vaginal delivery, 61% think that it is safer than vaginal delivery, 37% got a strong advice from her obstetrician to do caesarean. The results revealed that 84.5% of the women have an intention to have another caesarean in the next pregnancy. Twenty-nine (96.7%) of the obstetricians think that most of the cases of caesarean are not indicated, while 56.7% attributed that to money as it is usually done in private hospitals. Caesarean section is becoming a trend that may substitute normal vaginal delivery due to the "pushing" of the obstetricians and the increasing preference of women to lessen the pain.
Full article
International Medical Journal
Journal ID : IMJ-15-02-2020-254
Total View : 113

Abstract : One of the main factors in the process of pregnancy and breastfeeding is the nutritional needs in which the baby's growth process is influenced by maternal health conditions and nutritional status. This study aims to assess differences in infant growth in the group of mothers who obtain Moringa oleifera flour and iron-folic acid supplementation. This study used an experimental method with a Randomized Double Blind design with a controlled design. The study population was the group of pregnant and breastfeeding mothers, while the sample was40 pregnant women with the first group receiving Moringa Oleifera flour capsules and the second group receiving iron-folic acid capsules. Bivariate analysis was performed using chi-square and multivariate logistic regression to see the value of the Odds Ratio Test. There is a significant influence of Moringa flour intervention on the weight of 3 month old infants where the use of moringa oleifera (Odds Ratio Test 2,385) times better for growth than the use of iron tablets. Furthermore, there is no significant effect of Moringa flour intervention on the weight of an infant aged 6 months (p-value = 0.177), and the use of moringa oleifera (Odds Ratio Test 6.538) times greater than the use of iron tablets. There are different results from the intervention of moringa oleifera and Fe in infants aged 3 and 6 months, but specifically, the Moringa oleifera intervention group has a greater benefit than iron tablets. Therefore, moringa oleifera can be an alternative to meet the nutrition of pregnant women, breastfeeding mothers and especially the growth of the infants.
Full article
International Medical Journal
Journal ID : IMJ-15-02-2020-253
Total View : 130

Abstract : The prognosis of systemic lupus erythematosus (SLE) has greatly improved in recent years, resulting in an increased number of patients reporting musculoskeletal complications such as osteonecrosis of the femoral head. Total hip arthroplasty (THA) can be utilised to alleviate the pain associated with this; however postoperative outcomes in patients with SLE are uncertain. This article was a case report of 48 year old woman and a SLE patient who underwent a THA on the left hip. After the surgery, patient underwent immobilization with non weight-bearing and extension of the knee for three weeks. After six weeks, patient started physiotherapy to improve range of motion with passive and active movement. Patient evaluation revealed no pain and progressive recovery of muscular strength after four months and could be able to walk with walker. Total hip arthroplasty using contemporary techniques and current management protocols can provide reliable functional improvement in patients with osteonecrosis secondary to SLE.
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates